ArticleJournal of global health2026
Global burden of fall-related injuries attributable to low bone mineral density in women aged 50-69 years: inequalities, projections to 2050, and Mendelian randomisation.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Admission Braden Scale Score Is Associated with In-Hospital Mortality in ICU Patients Admitted After a Same-Level Fall: A Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Low bone mineral density (LBMD) increases fragility fracture risk and may contribute importantly to disability after falls. Within the Global Burden of Disease (GBD) framework, the attributable fall-related burden is better interpreted as fracture susceptibility and post-fall disability than as a direct effect on the occurrence of falls. However, the magnitude, inequality, and future trajectory of this burden in women aged 50-69 years remain unclear. Methods: Using GBD 2021 estimates from 1990-2021, we quantified LBMD-attributable fall-related disability-adjusted life years (DALYs), years lived with disability (YLDs), and age-standardised rates in women aged 50-69 years. Men were included for contextual comparison. We assessed temporal trends, socioeconomic inequality, frontier gaps, burden decomposition, and conditional projections to 2050. We performed two-sample Mendelian randomisation to examine associations of genetically predicted femoral-neck bone mineral density with falls and femoral fractures. Results: From 1990-2021, age-standardised DALY and YLD rates declined modestly, whereas absolute DALYs nearly doubled and YLDs increased markedly. In 2021, women had approximately 35-45% higher age-standardised disability-adjusted life-year rate (ASDR) and about 75% more YLDs than men aged 50-69 years. Relative inequality, as measured by the concentration index, was directionally positive but statistically uncertain, whereas absolute inequality remained substantial. Conditional projections suggested further declines in age-standardised rates by 2050 but continued growth in absolute disability burden. Genetically predicted lower femoral-neck bone mineral density showed no clear association with falls (inverse-variance weighted odds ratio (IVW OR) = 1.29; 95% CI = 0.86, 1.95) but was associated with higher risk of fracture of femur (OR = 1.71; 95% CI = 1.37, 2.14). Conclusions: LBMD-attributable fall-related injury burden in women aged 50-69 years remains a substantial and unequally distributed source of disability. The GBD and Mendelian randomisation findings suggest that LBMD contributes more strongly to fracture susceptibility and disability after falls than to fall occurrence itself, supporting earlier osteoporosis risk assessment and integrated bone-, muscle-, and fall-prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.